Health and Wellness

How One Brand Is Addressing—and Aims to Close—the Gender Pain Gap

Reckitt drug Nurofen is raising awareness of the fact that women's pain is often overlooked, under-treated or dismissed

A woman with a serious expression with the words See my pain placed over her face — Nurofen has committed to closing the gender pain gap.McCann London, Nurofen

By Brittaney Kiefer

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

Research shows that women’s pain has long been overlooked, ignored and dismissed through societal and medical biases. In a rare move for a brand, Reckitt drug Nurofen has launched a campaign to close the gender pain gap.

The gender pain gap refers to the phenomenon in which women’s pain is less understood and more mistreated compared to pain in men, due to systemic biases and inequalities. Factors behind the gap include a historic lack of medical research and mandatory training for healthcare professionals on women’s conditions, as well as ingrained gender bias in society.

an infrared image of a woman lying in bed

Bodyform’s Surreal Ad Tackles Another Taboo: the Period Sleep Gap

The U.K.

Brittaney Kiefer

Brittaney is Adweek's European creativity editor.

Recommended articles